IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 5, Issue 3 (2024)
J Clinic Care Skill 2024, 5(3): 145-150 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2024/04/24 | Accepted: 2024/08/31 | Published: 2024/09/20
Received: 2024/04/24 | Accepted: 2024/08/31 | Published: 2024/09/20
How to cite this article
Abbasi Larki R, Azad A, Jannesar R, Manzouri L, Jahanbani S. The Effect of Helicobacter Pylori Infection Eradication on Glomerular Filtration Rate in Patients with Chronic Kidney Disease. J Clinic Care Skill 2024; 5 (3) :145-150
URL: http://jccs.yums.ac.ir/article-1-251-en.html
URL: http://jccs.yums.ac.ir/article-1-251-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Department of Nephrology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
2- Department of Gastroenterology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
3- Department of Pathology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
4- Community and Preventive Medicine Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
5- “Department of Internal Medicine, Faculty of Medicine,” and “Medicinal Plants Research Center”, Yasuj University of Medical Sciences, Yasuj, Iran
2- Department of Gastroenterology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
3- Department of Pathology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
4- Community and Preventive Medicine Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
5- “Department of Internal Medicine, Faculty of Medicine,” and “Medicinal Plants Research Center”, Yasuj University of Medical Sciences, Yasuj, Iran
Abstract (735 Views)
Aims: Concomitant Helicobacter pylori (H. pylori) infection in patients with chronic kidney disease (CKD) may increase the risk of CKD progression. Maybe the eradication of Helicobacter pylori improves the Glomerular Filtration Rate (GFR), however, there is a challenge between studies. Therefore, this study aimed to demonstrate whether eradication of this infection improves GFR in CKD patients.
Materials & Methods: This is an interventional study on 270 CKD patients with GFR between 30 to 60 mL/min who were evaluated for H. pylori infection. A total of 79 patients were eligible for inclusion in the study. The patients underwent an early eradication treatment for H. pylori infection. The trend of changes in GFR was evaluated and compared in CKD patients in whom H. pylori infection was successfully eradicated (group A) to those whose infection had not been eradicated (group B) in a six-month follow-up period.
Findings: A total of 49 patients with chronic kidney disease (CKD) and a positive stool antigen test for H. pylori completed the study. In Group A, which received treatment for H. pylori infection, the mean glomerular filtration rate (GFR) showed an upward trend, rising from 48.54 ± 8.66 mL/min at baseline to 49.5±14.4 mL/min at six months. However, this increase was not statistically significant (P=0.18). In contrast, Group B exhibited a downward trend in GFR over the study period, decreasing from 45.77±7.92 mL/min at baseline to 45.48±14.33 mL/min at six months, with this change also not reaching statistical significance (p=0.48).
Conclusion: There is no significant difference in GFR between groups, however GFR in CKD patients with H. pylori infection eradication is increased.
Materials & Methods: This is an interventional study on 270 CKD patients with GFR between 30 to 60 mL/min who were evaluated for H. pylori infection. A total of 79 patients were eligible for inclusion in the study. The patients underwent an early eradication treatment for H. pylori infection. The trend of changes in GFR was evaluated and compared in CKD patients in whom H. pylori infection was successfully eradicated (group A) to those whose infection had not been eradicated (group B) in a six-month follow-up period.
Findings: A total of 49 patients with chronic kidney disease (CKD) and a positive stool antigen test for H. pylori completed the study. In Group A, which received treatment for H. pylori infection, the mean glomerular filtration rate (GFR) showed an upward trend, rising from 48.54 ± 8.66 mL/min at baseline to 49.5±14.4 mL/min at six months. However, this increase was not statistically significant (P=0.18). In contrast, Group B exhibited a downward trend in GFR over the study period, decreasing from 45.77±7.92 mL/min at baseline to 45.48±14.33 mL/min at six months, with this change also not reaching statistical significance (p=0.48).
Conclusion: There is no significant difference in GFR between groups, however GFR in CKD patients with H. pylori infection eradication is increased.
Keywords:
References
1. Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398(10302):786-802. [Link] [DOI:10.1016/S0140-6736(21)00519-5]
2. Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322(13):1294-304. [Link] [DOI:10.1001/jama.2019.14745]
3. Ghiasi B, Nazari H, Babarabiei MA, Raiesifar A. Prevalence and causes of chronic kidney disease in patients referred to the nephrology clinic in Ilam. J Ilam Univ Med Sci. 2023;31(1):52-9. [Persian] [Link]
4. Abassi MR, Safavi A, Haghverdi M, Saedi B. Sleep disorders in ESRD patients undergoing hemodialysis. Acta Med Iran. 2016;54(3):176-84. [Link]
5. Hejazi S, Nikbakht Sh, Nasiri ZarrinGhabaee D, Akaberi A, Nazari Sheyhaki A. Hope in caregivers and hemodialysis patients. North Khorasan Univ Med Sci. 2015;6(4):807-17. [Persian] [Link] [DOI:10.29252/jnkums.6.4.807]
6. Ammirati AL. Chronic kidney disease. REVISTA DA ASSOCIAÇÃO MÉDICA BRASILEIRA. 2020;66(Suppl 1):s03-9. [Link] [DOI:10.1590/1806-9282.66.s1.3]
7. Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr. 2009;90(2):407-14. [Link] [DOI:10.3945/ajcn.2008.27390]
8. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: A large population-based study. BMC Public Health. 2009;9:44. [Link] [DOI:10.1186/1471-2458-9-44]
9. Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, Jaruvongvanich V, Nakkala K, Rajapakse R, et al. Association of helicobacter pylori with chronic kidney diseases: A meta-analysis. Dig Dis Sci. 2017;62(8):2045-52. [Link] [DOI:10.1007/s10620-017-4516-z]
10. Crowe SE. Helicobacter pylori infection. N Engl J Med. 2019;380(12):1158-65. [Link] [DOI:10.1056/NEJMcp1710945]
11. Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. [Link] [DOI:10.1038/s41572-023-00431-8]
12. Stefano K, Marco M, Federica G, Laura B, Barbara B, Gioacchino L, et al. Helicobacter pylori, transmission routes and recurrence of infection: State of the art. Acta Biomed. 2018;89(Suppl 8):72-6. [Link]
13. Park SK. Extra-digestive manifestations of helicobacter pylori infection-An overview. In: Extradigestive manifestations of helicobacter pylori infection-An overview. London: IntechOpen; 2016. [Link] [DOI:10.5772/63226]
14. Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-9. [Link] [DOI:10.1053/j.gastro.2017.04.022]
15. Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, et al. Screening and eradication of helicobacter pylori for gastric cancer prevention: The Taipei global consensus. Gut. 2020;69(12):2093-112. [Link] [DOI:10.1136/gutjnl-2020-322368]
16. Darvishi M, Noori M, Nazer MR, Soleiman-Meigooni S, Forootan M. The relationship between helicobacter pylori and extra-gastrointestinal infections. Iran J Med Microbiol. 2020;14(6):543-65. [Persian] [Link] [DOI:10.30699/ijmm.14.6.543]
17. Rogha M, Nikvarz M, Pourmoghaddas Z, Shirneshan K, Dadkhah D, Pourmoghaddas M. Is helicobacter pylori infection a risk factor for coronary heart disease?. ARYA Atheroscler. 2012;8(1):5-8. [Link]
18. Ala S, Maleki I, Araghi AS, Sahebnasagh A, Shahraki A. Helicobacter pylori eradication in the management of glaucoma. Caspian J Intern Med. 2020;11(2):143-9. [Link]
19. Kyburz A, Müller A. Helicobacter pylori and extragastric diseases. Curr Top Microbiol Immunol. 2017;400:325-47. [Link] [DOI:10.1007/978-3-319-50520-6_14]
20. Goni E, Franceschi F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016;21(Suppl 1):45-8. [Link] [DOI:10.1111/hel.12340]
21. Rabelo-Gonçalves EM, Roesler BM, Zeitune JM. Extragastric manifestations of helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol. 2015;7(30):2968-79. [Link] [DOI:10.4254/wjh.v7.i30.2968]
22. Franceschi F, Gasbarrini A, Polyzos SA, Kountouras J. Extragastric diseases and helicobacter pylori. Helicobacter. 2015;20(Suppl 1):40-6. [Link] [DOI:10.1111/hel.12256]
23. Lin SY, Lin CL, Liu JH, Yang YF, Huang CC, Kao CH. Association between helicobacter pylori infection and the subsequent risk of end‐stage renal disease: A nationwide population‐based cohort study. Int J Clin Pract. 2015;69(5):604-10. [Link] [DOI:10.1111/ijcp.12602]
24. Hooman N, Mehrazma M, Talachian E, Otukesh H, Nakhaii S. Helicobacter pylori infection in pediatric candidates for kidney transplantation. Iran J Kidney Dis. 2011;5(2):124-9. [Link]
25. Shin SP, Bang CS, Lee JJ, Baik GH. Helicobacter pylori infection in patients with chronic kidney disease: A systematic review and meta-analysis. Gut Liver. 2019;13(6):628-41. [Link] [DOI:10.5009/gnl18517]
26. Chang SS, Hu HY. Lower helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease. J Chin Med Assoc. 2014;77(7):354-9. [Link] [DOI:10.1016/j.jcma.2014.04.004]
27. Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, Lekuthai N, Jaruvongvanich V, Nakkala K, et al. Association between helicobacter pylori and end-stage renal disease: A meta-analysis. World J Gastroenterol. 2017;23(8):1497-506. [Link] [DOI:10.3748/wjg.v23.i8.1497]
28. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75(1):96-103. [Link] [DOI:10.1038/ki.2008.508]
29. Khazaei MR, Imanieh MH, Hosseini AG. Gastrointestinal evaluation in pediatric kidney transplantation candidates. Iran J Kidney Dis. 2008;2(1):40-5. [Link]
30. Nasri H. Helicobacter pylori and serum magnesium level in hemodialysis patients. Jundishapur J Microbiol. 2014;7(2):e11095. [Link] [DOI:10.5812/jjm.11095]
31. Lai CY, Yang TY, Lin CL, Kao CH. Helicobacter pylori infection and the risk of acute coronary syndrome: A nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2015;34(1):69-74. [Link] [DOI:10.1007/s10096-014-2207-7]
32. Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, et al. Azithromycin in a triple therapy for H. pylori eradication in active duodenal ulcer. World J Gastroenterol. 2002;8(5):879-82. [Link] [DOI:10.3748/wjg.v8.i5.879]
33. Sugimoto M, Yamaoka Y. Review of helicobacter pylori infection and chronic renal failure. Ther Apher Dial. 2011;15(1):1-9. [Link] [DOI:10.1111/j.1744-9987.2010.00851.x]
34. Schoonjans R, Van VB, Vandamme W, Van HN, Verdievel H, Vanholder R, et al. Dyspepsia and gastroparesis in chronic renal failure: The role of helicobacter pylori. Clin Nephrol. 2002;57(3):201-7. [Link] [DOI:10.5414/CNP57201]
35. Kalantar-Zadeh K, Stenvinkel P, Pillon L, Kopple JD. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther. 2003;10(3):155-69. [Link] [DOI:10.1053/j.arrt.2003.08.008]
36. Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z, et al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci. 2014;59(9):2109-17. [Link] [DOI:10.1007/s10620-014-3202-7]
37. Hafizi M, Mardani S, Borhani A, Ahmadi A, Nasri P, Nasri H. Association of helicobacter pylori infection with serum magnesium in kidney transplant patients. J Ren Inj Prev. 2014;3(4):101-5. [Link]
38. Alimadadi M, Seyyedmajidi M, Amirkhanlou S, Hafezi AA, Homapour S, Vafaeimanesh J, et al. Impact of creatinine clearance on helicobacter pylori eradication rate in patients with peptic ulcer disease. Iran J Kidney Dis. 2015;9(6):427-32. [Link]
39. Abdulrahman IS, Al-Quorain AA. Prevalence of gastroesophageal reflux disease and its association with helicobacter pylori infection in chronic renal failure patients and in renal transplant recipients. Saudi J Gastroenterol. 2008;14(4):183-6. [Link] [DOI:10.4103/1319-3767.41741]
40. Moriyama T, Matsumoto T, Hirakawa K, Ikeda H, Tsuruya K, Hirakata H, et al. Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis. J Gastroenterol. 2010;45(5):515-22. [Link] [DOI:10.1007/s00535-009-0196-6]
41. Wang X, Jia Z, Zhang Y, Kou C, Jiang J. Association of helicobacter pylori infection with estimated glomerular filtration rate in a Chinese population. Infect Genet Evol. 2021;96:105102. [Link] [DOI:10.1016/j.meegid.2021.105102]